Brain cancer trial aims to boost radiation without extra harm
NCT ID NCT05871021
First seen Jan 11, 2026 · Last updated Apr 24, 2026 · Updated 20 times
Summary
This study tests whether giving a higher dose of radiation along with a drug called bevacizumab can help people with a fast-growing brain tumor called glioblastoma live longer. The drug is meant to protect healthy tissue from the extra radiation. About 146 adults aged 18 to 70 with a specific type of glioblastoma will take part. The goal is better tumor control without more side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Radiation Oncology
RECRUITINGTübingen, 72076, Germany
Contact
Conditions
Explore the condition pages connected to this study.